Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
L-arginine supplementation for the prevention of adverse birth outcomes in pregnancies complicated by malaria
FY 2018-19
Summary
L-arginine is part of a normal protein diet, and an important building block for a growing fetus and developing placenta during pregnancy. Certain infections, such as malaria, can cause L-arginine levels to fall. Millions of women who live in parts of the world with high rates of malaria infection also suffer from dietary protein deficiencies in L-arginine. These women are at high risk of having poor pregnancy outcomes such as still birth, preterm and growth-restricted babies. Infants who are born preterm are at risk for death early in life.
In this study, our goal is to develop a safe and effective L-arginine supplement that can be used by women who have poor access to nutritious food and are at high risk of malaria infection pregnancy in order to help them have healthy pregnancies and healthy babies. To do this, we have defined two key goals:
1. To assess L-arginine levels in blood samples taken from women in subSaharan Africa during their first trimester of pregnancy and determine if low levels early in gestation predict poor pregnancy outcomes and,
2. To conduct a large randomized, double blinded placebo control trial in Tanzania using an L-arginine supplement that we will develop for use by pregnant women. The goal of this study will be to see if L-arginine supplementation improves the pregnancy outcomes of women who are likely to have poor protein intake as part of their regular diet and are at high risk of contracting malaria in pregnancy
If our intervention is successful, it will hold great promise for the millions of pregnant women who live in low-resource countries in places such as subSaharan Africa. L-arginine is readily sourced from groundnuts and could be made affordably, locally and sustainably to support the health of women during pregnancy, and help them have healthy children.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
396642
Name
Wright Julie F
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
L-arginine supplementation for the prevention of adverse birth outcomes in pregnancies complicated by malaria
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Adverse Pregnancy Outcomes; L-Arginine; Malaria; Pregnancy; Preterm Birth; Randomized Control Trial; Resource-Poor Settings; Supplementation; Women'S Reproductive Health
Abstract
L-arginine is part of a normal protein diet, and an important building block for a growing fetus and developing placenta during pregnancy. Certain infections, such as malaria, can cause L-arginine levels to fall. Millions of women who live in parts of the world with high rates of malaria infection also suffer from dietary protein deficiencies in L-arginine. These women are at high risk of having poor pregnancy outcomes such as still birth, preterm and growth-restricted babies. Infants who are born preterm are at risk for death early in life.
In this study, our goal is to develop a safe and effective L-arginine supplement that can be used by women who have poor access to nutritious food and are at high risk of malaria infection pregnancy in order to help them have healthy pregnancies and healthy babies. To do this, we have defined two key goals:
1. To assess L-arginine levels in blood samples taken from women in subSaharan Africa during their first trimester of pregnancy and determine if low levels early in gestation predict poor pregnancy outcomes and,
2. To conduct a large randomized, double blinded placebo control trial in Tanzania using an L-arginine supplement that we will develop for use by pregnant women. The goal of this study will be to see if L-arginine supplementation improves the pregnancy outcomes of women who are likely to have poor protein intake as part of their regular diet and are at high risk of contracting malaria in pregnancy
If our intervention is successful, it will hold great promise for the millions of pregnant women who live in low-resource countries in places such as subSaharan Africa. L-arginine is readily sourced from groundnuts and could be made affordably, locally and sustainably to support the health of women during pregnancy, and help them have healthy children.
Competitiondate
201810
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Wright, Julie F
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~